secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0000064803-26-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health Q4 revenue $105.7B (+8.2%); adj. EPS $1.09 vs $1.19; 2026 adj. EPS guide $7.00-$7.20
--------------------------------------------------------------------------------

- Full-year 2025 revenue record $402.1B (+7.8%); GAAP EPS $1.39 (incl. $5.7B goodwill impairment), Adj. EPS $6.75 (+24.5%).
- Q4 Health Care Benefits segment adj. op. loss ($676M) widened from ($439M) on IRA Medicare Part D seasonality.
- Pharmacy & Consumer Wellness Q4 adj. op. income $1,911M (+8.7%) on higher prescription volume including Rite Aid acquisitions.
- 2026 guidance: GAAP EPS $5.94-$6.14; Adj. EPS $7.00-$7.20; cash flow from operations at least $9.0B (down from prior $10.0B).
- Medical membership 26.6M, down 0.5M YoY; days claims payable 38.9 (down 3.6 days from Q3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000009/0000064803-26-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480326000009/cvs-20260210.htm
  HTML page:      https://secwatch.observer/filing/0000064803-26-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer